Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease, according to a study from Karolinska...Weekly Roundup
British drugmaker AstraZeneca has announced that its immunotherapy cancer treatment Imfinzi has been granted a speedy review by the US medicines watchdog for the...HIV/AIDS
In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organisation funded primarily by Unitaid to...Medico-Legal
According to a consumer lawsuit, the lifesaving combination-drug “cocktails” to treat HIV infection were the focus of anti-competitive schemes by the US’s leading...
January 16th, 2019Memorial Sloan Kettering Cancer Centre, one of the world’s leading research institutions, has announced that it would bar its top executives from serving on corporate...
January 9th, 2019
Dr José Baselga, the former chief medical officer of Memorial Sloan Kettering Cancer Centre, resigned under pressure as one of the editors-in-chief of the American...
Swiss drugmaker Roche has announced that its Tecentriq immunotherapy in combination with Avastin and chemotherapy has won US Food and Drug Administration approval as a...
September 12th, 2018
One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his...
The US Food and Drug Administration (FDA) has warned that a serious genital infection has been reported in patients taking a certain class of diabetes drugs, with one...Weekly Roundup
It has been 20 years since Viagra was introduced, and Pfizer is still searching for another drug with as much earning power as the revolutionary blue erection pill. If...
